Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
114,331,829
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
35,346,074
-
Shares change
-
+9,934,585
-
Total reported value, excl. options
-
$215,961,575
-
Value change
-
+$67,123,779
-
Number of buys
-
46
-
Number of sells
-
-32
-
Price
-
$6.11
Significant Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q4 2017
92 filings reported holding FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q4 2017.
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35,346,074 shares
of 114,331,829 outstanding shares and own 30.92% of the company stock.
Largest 10 shareholders include FMR LLC (7,861,643 shares), FRANKLIN RESOURCES INC (6,035,779 shares), Redmile Group, LLC (5,465,486 shares), Casdin Capital, LLC (2,600,000 shares), Polaris Venture Management Co. V, L.L.C. (2,473,186 shares), BlackRock Inc. (1,705,293 shares), Vanguard Group Inc (1,459,136 shares), 683 Capital Management, LLC (853,800 shares), Endurant Capital Management LP (556,679 shares), and STATE STREET CORP (534,969 shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.